These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15227166)

  • 1. Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction.
    Willerson JT; Buja LM
    Tex Heart Inst J; 1990; 17(3):157-64. PubMed ID: 15227166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and thrombotic complications.
    Willerson JT
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S13-20. PubMed ID: 1717768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
    Willerson JT; Golino P; Eidt J; Campbell WB; Buja LM
    Circulation; 1989 Jul; 80(1):198-205. PubMed ID: 2661053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators.
    Willerson JT; Yao SK; Ferguson JJ; Anderson HV; Golino P; Buja LM
    Tex Heart Inst J; 1991; 18(4):243-7. PubMed ID: 15227406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
    Machado AP; Saavedra JA; Ribeiro C
    Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes.
    Willerson JT; Golino P; Eidt J; Yao SK; Buja LM
    Am J Cardiol; 1990 Nov; 66(16):48G-53G. PubMed ID: 2146868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
    Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis/platelets and other blood factors in acute coronary syndromes.
    Stein B; Badimon L; Israel DH; Badimon JJ; Fuster V
    Cardiovasc Clin; 1989; 20(1):105-29. PubMed ID: 2653627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
    Willerson JT
    Tex Heart Inst J; 1995; 22(1):13-9. PubMed ID: 7787465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that combined thromboxane A2 and serotonin receptor blockade might prevent coronary artery thrombosis and the conversion from chronic to acute coronary heart disease syndromes.
    Willerson JT; Golino P; Eidt J; Yao S; Buja LM
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):211-8. PubMed ID: 2130933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial cellular alterations during myocardial ischemia and evolving infarction.
    Willerson JT; Buja LM
    Postgrad Med; 1988 Feb; Spec No():69-75. PubMed ID: 2894662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should all patients with risk factors for ischemic heart disease receive aspirin?
    Willerson JT; Mueller SD; Ferguson JJ
    Tex Heart Inst J; 1992; 19(2):73-8. PubMed ID: 15227418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different?
    Ambrose JA
    J Am Coll Cardiol; 1992 Jun; 19(7):1653-8. PubMed ID: 1593062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction).
    Winther K; Husted SE; Vissinger H
    Pharmacol Toxicol; 1994 Mar; 74(3):141-7. PubMed ID: 8008719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction.
    Horowitz JD
    Am J Med; 1991 Sep; 91(3C):113S-117S. PubMed ID: 1928201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance.
    Golino P; Crea F; Willerson JT
    Ital Heart J; 2002 Apr; 3(4):220-5. PubMed ID: 12025369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction between thrombocytes and blood vessel wall--significance for acute ischemic coronary syndromes].
    Kristensen SD; Husted SE; Nielsen HK; Ravn HB; Vissinger H
    Ugeskr Laeger; 1995 Apr; 157(16):2295-8. PubMed ID: 7652964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.